HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paresh Vyas Selected Research

GATA1 Transcription Factor

1/2021Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
12/2006Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.
2/2006Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
6/2005Selective impairment of platelet activation to collagen in the absence of GATA1.
2/2005GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
4/2004Natural history of GATA1 mutations in Down syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paresh Vyas Research Topics

Disease

28Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2022 - 06/2010
15Neoplasms (Cancer)
11/2021 - 06/2006
14Leukemia
11/2020 - 01/2011
9Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2022 - 09/2010
9Down Syndrome (Down's Syndrome)
01/2021 - 04/2004
5Thrombocytopenia (Thrombopenia)
11/2021 - 06/2005
5Residual Neoplasm
01/2018 - 10/2009
4Myeloproliferative Disorders (Myeloproliferative Disorder)
01/2021 - 04/2004
4Hemorrhage
10/2016 - 06/2005
4Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
02/2007 - 04/2004
3Anemia
01/2021 - 11/2005
3Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 09/2010
3Bone Marrow Failure Disorders
10/2016 - 10/2015
2Neutropenia
11/2021 - 01/2021
2Melanoma (Melanoma, Malignant)
04/2012 - 09/2010
2Acute Promyelocytic Leukemia
01/2011 - 11/2010
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
08/2022
1Pneumonia (Pneumonitis)
11/2021
1Febrile Neutropenia
11/2021
1Starvation
11/2021
1Infections
01/2021
1Multiple Myeloma
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2020
1Acute Erythroblastic Leukemia (Erythroleukemia)
01/2020
1Asthenia
01/2020
1Fatigue
01/2020
1Nausea
01/2020
1Diarrhea
01/2020
1Body Weight (Weight, Body)
01/2020
1Dizziness (Lightheadedness)
01/2020
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Hyperbilirubinemia
10/2017
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2017
1Hemolysis
01/2017
1Thalassemia
01/2017
1Transfusion Reaction
10/2016

Drug/Important Bio-Agent (IBA)

10Azacitidine (5 Azacytidine)FDA Link
01/2022 - 09/2010
8Transcription Factors (Transcription Factor)IBA
01/2020 - 02/2007
6enasidenibIBA
06/2022 - 10/2017
6GATA1 Transcription FactorIBA
01/2021 - 04/2004
5Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021 - 10/2017
5Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2006
4DNA (Deoxyribonucleic Acid)IBA
01/2019 - 02/2005
3glasdegibIBA
08/2022 - 10/2020
3Biological ProductsIBA
02/2015 - 08/2012
2venetoclaxIBA
01/2022 - 10/2020
2ChromatinIBA
11/2021 - 01/2019
2Histones (Histone)IBA
11/2021 - 01/2019
2ArginaseIBA
11/2021 - 08/2013
2Arginine (L-Arginine)FDA Link
11/2021 - 01/2019
2Lenalidomide (CC 5013)FDA Link
01/2021 - 09/2010
2Cytarabine (Cytosar-U)FDA LinkGeneric
12/2020 - 10/2020
2RNA Splicing FactorsIBA
01/2018 - 06/2017
2recombinant FVIIa (rFVIIa)FDA Link
10/2016 - 01/2016
2Fibrinogen (Factor I)FDA Link
10/2016 - 01/2016
2Thrombopoietin (c-mpl Ligand)IBA
10/2016 - 01/2016
2Peptides (Polypeptides)IBA
02/2016 - 06/2006
2AntigensIBA
04/2012 - 09/2010
1Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA
11/2021
1CitrullineIBA
11/2021
1ivosidenibIBA
01/2021
1cc-486IBA
01/2021
1pomalidomideIBA
01/2021
1EnzymesIBA
01/2021
1Glycoproteins (Glycoprotein)IBA
01/2021
1Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link
01/2021
1ZincIBA
11/2020
1fms-Like Tyrosine Kinase 3IBA
10/2020
1AnthracyclinesIBA
10/2020
1HematinicsIBA
01/2020
1luspaterceptIBA
01/2020
1EPZ-5676IBA
01/2019
1isocitric acid (isocitrate)IBA
01/2019
1Proto-Oncogene Proteins c-etsIBA
01/2019
1Indicators and Reagents (Reagents)IBA
01/2018
1VorinostatFDA Link
11/2017
1GlobinsIBA
01/2017
1Factor XIII (Coagulation Factor XIII)IBA
10/2016
1InterleukinsIBA
10/2016
1Pharmaceutical PreparationsIBA
10/2016
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
10/2016
1AntibodiesIBA
10/2016
1Tranexamic Acid (AMCA)FDA Link
10/2016
1Factor VIIa (Activated Factor VII)IBA
10/2016
1RG7112IBA
02/2016
1NucleophosminIBA
02/2016
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2016
1Neoplasm Antigens (Tumor Antigens)IBA
02/2016

Therapy/Procedure

15Therapeutics
06/2022 - 09/2010
9Stem Cell Transplantation
01/2021 - 06/2010
5Drug Therapy (Chemotherapy)
08/2022 - 11/2005
2Platelet Transfusion (Blood Platelet Transfusions)
10/2016 - 01/2016
2Transplantation
02/2016 - 04/2012
2Cell Transplantation
02/2015 - 01/2015
1Remission Induction
10/2020
1Transjugular Intrahepatic Portasystemic Shunt
01/2019
1Immunotherapy
01/2019
1Hematopoietic Stem Cell Transplantation
01/2019
1Induction Chemotherapy
11/2016